21-Aug-2026
Business Wire (Mon, 17-Aug 7:30 AM ET)
Business Wire (Fri, 14-Aug 7:30 AM ET)
Business Wire (Fri, 7-Aug 7:00 AM ET)
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
Business Wire (Fri, 24-Jul 7:30 AM ET)
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
Business Wire (Tue, 21-Jul 7:30 AM ET)
Business Wire (Mon, 15-Jun 7:00 AM ET)
Business Wire (Mon, 8-Jun 7:30 AM ET)
Business Wire (Fri, 29-May 7:00 AM ET)
Canopy Growth's Acquisition of MTL Cannabis Set to Establish New Medical Cannabis Leader in Canada
Market Chameleon (Tue, 16-Dec 5:30 AM ET)
Canopy Growth Bets on Medical Market With Dedicated DOJA Facility—What This Move Signals for CGC
Market Chameleon (Thu, 9-Oct 7:20 AM ET)
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Canopy Growth - Common Shares trades on the NASDAQ stock market under the symbol CGC.
As of August 21, 2026, CGC stock price was flat at $1.05 with 5,307,131 million shares trading.
CGC has a beta of 1.03, meaning it tends to be more sensitive to market movements. CGC has a correlation of 0.03 to the broad based SPY ETF.
CGC has a market cap of $471.76 million. This is considered a Small Cap stock.
Last quarter Canopy Growth - Common Shares reported $59 million in Revenue and -$.02 earnings per share. This beat revenue expectation by $110,000 and exceeded earnings estimates by $.02.
In the last 3 years, CGC traded as high as $19.20 and as low as $.77.
The top ETF exchange traded funds that CGC belongs to (by Net Assets): MJ, YOLO.
CGC has underperformed the market in the last year with a return of -15.3%, while the SPY ETF gained +21.7%. In the last 3 month period, CGC fell short of the market, returning -1.9%, while SPY returned +3.4%. However, in the most recent 2 weeks CGC has outperformed the stock market by returning +8.2%, while SPY returned -1.0%.
CGC support price is $1.02 and resistance is $1.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CGC shares will trade within this expected range on the day.